Skip to main content
Caplight Logo









Nanodropper, Inc.

Nanodropper, Inc.

Private
Rochester, MinnesotaHealthcare & Life Scienceshttps://nanodropper.com/

Last Round

Grant

Dec 11, 2024

Total Funding Raised

$2.29M

Momentum

Top 25%

of companies Caplight tracks

Company Overview

Nanodropper, Inc. is a medical device company that develops a patient-centered, volume-reducing adapter for eyedrop bottles designed to minimize medication waste and improve treatment adherence for chronic eye conditions.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, D2C Brands, E-commerce

Business Model

B2B

Customer Profile

Hardware Sales

AI Layer

Application

Keywords

eye drop adaptermedical deviceophthalmic medicationmedication waste reductionglaucoma treatmentFDA-cleared deviceD2C medicaleye drop aidmedication cost savingsophthalmology suppliesmedication adherencehealth tech

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Nanodropper, Inc. Comparables

Compare Nanodropper, Inc. with similar companies based on industry and business-model similarity.

Nanodropper, Inc. comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
Precision Dropper
85%
Universal Adherence LLC
82%
AK Technology AS
79%

Nanodropper, Inc. Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
GrantDec 11, 2024
GrantSep 20, 2021
SeedApr 19, 2021
GrantAug 19, 2020
SAFEJun 30, 2020
Grant
Jun 30, 2020

Key People

Founding team and executive leadership

Allisa Song

Founder And CEO

Founding Team

Elias B.

Chief Operating Officer

Executive Team

Nanodropper, Inc. Investors

Notable investors and investment history

Market signals

Structured signals derived from secondary market and firmographic data.

  • Jul 25, 2026

    Monthly visitors increased 30% to 8.7K.

  • Sep 29, 2025

    Added EyeProGPO, LLC, a group purchasing organization.

Nanodropper, Inc. Filings

Explore SEC and related filing metadata, where available.

Nanodropper, Inc. filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Nanodropper, Inc.'s valuation, stock price, and market status.

Is Nanodropper, Inc. a public or private company?

Nanodropper, Inc. is a private company.

What is the current stock price of Nanodropper, Inc.?

Nanodropper, Inc. is a private company with no public stock price. No recent secondary market data is available.

How much is Nanodropper, Inc. worth (valuation)?

Valuation information for Nanodropper, Inc. is not publicly available.

Can I buy Nanodropper, Inc. stock?

Nanodropper, Inc. shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Nanodropper, Inc.'s last funding round?

Nanodropper, Inc.'s most recent funding round was Seed on April 19, 2021.

Who are the main investors in Nanodropper, Inc.?

Key investors in Nanodropper, Inc. include Golden Seeds.

Will Nanodropper, Inc. IPO soon?

No public IPO plans have been announced for Nanodropper, Inc..

How can I track Nanodropper, Inc. secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Nanodropper, Inc.'s secondary market activity and sign up for updates.

Firmographic Details

HeadquartersRochester, Minnesota
Employee Range9
Year Founded2018
Last FundingDec 11, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?